What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects

Rike van Eekeren (), Leàn Rolfes, Andries S. Koster, Lara Magro, Gurumurthy Parthasarathi, Hussain Al Ramimmy, Tim Schutte, Daisuke Tanaka, Eugène van Puijenbroek and Linda Härmark
Additional contact information
Rike van Eekeren: Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Centre For Pharmacovigilance in Education and Patient Reporting
Leàn Rolfes: Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Centre For Pharmacovigilance in Education and Patient Reporting
Andries S. Koster: University of Utrecht
Lara Magro: University of Verona
Gurumurthy Parthasarathi: JSS University
Hussain Al Ramimmy: Ministry of Health
Tim Schutte: VU University Medical Center
Daisuke Tanaka: WHO
Eugène van Puijenbroek: Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Centre For Pharmacovigilance in Education and Patient Reporting
Linda Härmark: Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Centre For Pharmacovigilance in Education and Patient Reporting

Drug Safety, 2018, vol. 41, issue 11, No 2, 1003-1011

Abstract: Abstract Adverse drug reactions (ADRs) can cause serious health problems, as shown in studies about drug-related hospitalizations. To build knowledge of and raise awareness about ADRs among healthcare professionals, more education in the field of ADRs and pharmacovigilance (PV) is needed. No standard exists for teaching PV at universities for medical, pharmacy, dentistry and nursing students, so a core curriculum needs to be developed to teach important aspects of PV to students. In September 2016, a stakeholders’ meeting was initiated on behalf of the World Health Organization (WHO) and organized by the Netherlands Pharmacovigilance Centre Lareb. This meeting addressed and agreed on the PV competencies students need to develop and what key aspects of the subject should be taught. Five key aspects were identified: understanding the importance of PV in the context of pharmacotherapy, and preventing, recognizing, managing and reporting ADRs. Since time and resources for PV education are limited, elements of the WHO PV core curriculum for university teaching were designed to be integrated into existing courses but can be used as a stand-alone programme. The basis of and outline for the WHO PV core curriculum for university teaching are addressed in this paper. It is expected that PV competencies for students are vital for their contribution to safe use of medicines in the future. In addition, this article aims to stimulate discussion on this subject and promote collaboration between universities, national PV centres and other stakeholders to integrate key aspects of PV in their educational programmes.

Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://link.springer.com/10.1007/s40264-018-0681-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0681-z

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-018-0681-z

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().